Japan Salicylic Acid Market to Reach USD 69.85 Million by 2032, Growing at a CAGR of 7.6% During 2026–2032

Japan Salicylic Acid Market was valued at USD 41.83 million in 2025 and is projected to grow from USD 45.01 million in 2026 to USD 69.85 million by 2032, registering a CAGR of 7.6% during the forecast period. Market expansion is primarily supported by rising pharmaceutical demand, increasing adoption of dermatological and functional skincare products, and evolving regulatory measures aimed at strengthening the supply security and quality standards of critical pharmaceutical ingredients. As salicylic acid serves as a key raw material in aspirin production and topical treatments for acne, warts, and other skin conditions, its demand continues to benefit from Japan’s aging demographic profile and healthcare requirements.

Furthermore, regulatory developments continue to shape purchasing behavior across pharmaceutical and cosmetic industries. The implementation of stricter quality requirements under the Japanese Pharmacopoeia and updates to quasi-drug ingredient standards are increasing demand for high-purity, specification-controlled salicylic acid grades. At the same time, Japan’s advanced chemical manufacturing capabilities and focus on specialty chemicals are supporting the production of consistent-quality inputs required by regulated healthcare and skincare applications. These factors collectively reinforce the market’s transition toward higher-value salicylic acid products.

From a segmentation perspective, Powder/Crystal form dominated the market with a 70% share in 2025 due to its superior stability, ease of transportation, longer shelf life, and compatibility with pharmaceutical manufacturing standards. Regionally, market growth is supported by Japan’s strong pharmaceutical production base, expanding dermatology and aesthetic medicine sector, and continued investments in high-value skincare manufacturing. Recent developments, including Shiseido’s consolidation of skincare production into Japan and regulatory clarifications for quasi-drug approvals, are expected to further strengthen domestic demand for pharmaceutical-grade and cosmetic-grade salicylic acid over the coming years, as stated in the recent report “Japan Salicylic Acid Market Analysis, 2026”.

Japan Salicylic Acid Market Highlights

Japan Salicylic Acid Market was valued at USD 41.83 million in 2025.
The market is projected to reach USD 69.85 million by 2032.
The market is expected to grow at a CAGR of 7.6% during 2026–2032.
Pharmaceuticals led the market by application, accounting for 42% share in 2025.
Powder/Crystal dominated the market by form, holding 70% of total market revenue in 2025.
The market remains consolidated, with the top five companies collectively accounting for 72% of total market revenue.
Leading companies include Seqens Group SAS, Shandong Xinhua Pharmaceutical Co., Ltd., Zhenjiang Gaopeng Pharmaceutical Co., Ltd., Merck KGaA, and Thermo Fisher Scientific Inc.

Japan Salicylic Acid Market Segmentation

By Application

Pharmaceuticals
- Medicine Ingredient Production
- Skin Treatment Medicines
Skincare & Cosmetics
- Acne Treatment Products
- Exfoliants & Peels
- Cleansers & Toners
- Serums & Other Skincare
Hair Care
- Anti-Dandruff Shampoos
- Scalp & Other Hair Treatments
Others
- Farming & Plant Products
- Dyes, Fragrances & Specialty Chemicals
- Other Industrial Uses

By Form

Powder/Crystal
Liquid

Key Companies

Seqens Group SAS
Shandong Xinhua Pharmaceutical Co., Ltd. (parent: Shandong Hualu Holdings Co., Ltd.)
Zhenjiang Gaopeng Pharmaceutical Co., Ltd.
Merck KGaA
Thermo Fisher Scientific Inc.
Tokyo Chemical Industry Co., Ltd.
FUJIFILM Wako Pure Chemical Corporation (parent: FUJIFILM Holdings Corporation)
Kanto Chemical Co., Inc.
UBE Corporation (formerly API Corporation)
Kishida Chemical Co., Ltd.